Table 4 Adjusted hazard ratios for predictors of primary outcomes in total study cohort (Group 1)

 50–64

1.018

0.841

2.058

0.003

2.013

0.078

2.020

< 0.001

 65–69

1.309

0.004

2.690

< 0.001

2.162

0.063

2.250

< 0.001

 70–74

1.308

0.003

3.229

< 0.001

3.572

0.001

2.962

< 0.001

 75–79

1.676

< 0.001

3.736

< 0.001

4.804

< 0.001

3.736

< 0.001

 80–84

2.038

< 0.001

4.476

< 0.001

5.160

< 0.001

4.251

< 0.001

 85 and over

2.745

< 0.001

4.953

< 0.001

8.894

< 0.001

6.476

< 0.001

Female sex (vs male)

0.887

< 0.001

0.905

0.085

0.789

0.002

0.782

< 0.001

STEMI as index event (vs NSTEMI)

0.881

< 0.001

1.118

0.074

0.842

0.066

0.843

< 0.001

PCI or CABG related to index MI

0.650

< 0.001

0.673

< 0.001

0.502

< 0.001

0.493

< 0.001

Atrial fibrillation

1.014

0.725

1.408

< 0.001

1.057

0.528

1.143

0.003

Diabetes mellitus

1.371

< 0.001

1.257

< 0.001

1.494

< 0.001

1.361

< 0.001

Chronic renal failure

1.788

< 0.001

1.310

0.062

1.265

0.193

1.762

< 0.001

Dementia/Alzheimer’s disease

0.979

0.726

0.969

0.768

2.029

< 0.001

2.541

< 0.001

Ischemic stroke or TIA

1.114

0.017

4.169

< 0.001

1.601

< 0.001

1.332

< 0.001

Major bleedings

1.170

0.002

1.144

0.126

1.243

0.052

1.352

< 0.001

Hypertension

0.910

0.332

1.319

0.245

0.659

0.052

0.582

< 0.001

Hyperlipidemia

1.016

0.701

0.974

0.745

0.721

< 0.001

0.616

< 0.001

Congestive heart failure

1.385

< 0.001

1.219

0.002

2.000

< 0.001

2.018

< 0.001

Severe liver disease

1.232

0.353

1.870

0.061

0.721

0.645

1.283

0.381

COPD

1.156

0.032

0.950

0.706

1.842

< 0.001

1.915

< 0.001

Malignancy

1.160

0.003

1.272

0.006

0.975

0.841

1.668

< 0.001